IV or Subcutaneous Prostacyclin Pumps: When Used for PAH?

When patients with idiopathic or heritable pulmonary arterial hypertension (PAH) are not reaching their treatment goals on oral medications alone, their medical team may recommend adding a continuous intravenous (IV) or subcutaneous pump ^[1]. This is rarely a direct swap; instead, the pump is usually added to your existing pills to provide more aggressive support ^[2]. This escalation is most strongly considered when a patient’s disease is classified as “high risk” or “intermediate-high risk” for progression despite optimized oral therapy ^[1][3].

Understanding Your “Risk Status”

In PAH care, specialists regularly estimate your risk of the disease worsening or requiring hospitalization. They do this by looking at multiple factors together, rather than a single test ^[3]. These include:

• Symptoms and functional class: How much your symptoms limit daily activities (often measured by the World Health Organization or WHO functional class).
• Exercise capacity: How far you can walk in 6 minutes.
• Heart strain markers: Blood tests like BNP or NT-proBNP.
• Heart function: Right heart catheterization or echocardiogram measurements that show how well your heart is pumping ^[4].

The ultimate goal of PAH treatment is to reach a low-risk status ^[3]. For some scoring systems, this involves targets like walking more than 440 meters in 6 minutes and having minimal symptoms ^[5]. If your tests show you are at an “intermediate-low risk,” your doctor might simply adjust your oral medications ^[1]. However, if you remain in the “intermediate-high” or “high” risk categories, or if you experience severe events like fainting (syncope), right heart failure, or hospitalizations, your team will urgently consider adding continuous pump therapy ^[6][7].

Why a Pump? The Evidence for Severe PAH

Continuous IV epoprostenol (a type of prostacyclin) has the strongest randomized clinical trial evidence for improving survival in severe idiopathic PAH, making it a cornerstone therapy for high-risk patients ^[8][9].

Medications like epoprostenol have a very short half-life—meaning they are cleared from your body in a matter of minutes ^[10]. Because they do not last long enough to be taken as a pill, they must be infused continuously, 24 hours a day, 7 days a week. Another commonly used medication, treprostinil, has a slightly longer half-life but also requires continuous infusion when given via a pump ^[10].

The Reality of 24/7 Infusion: IV vs. Subcutaneous

Wearing a continuous pump is a major life adjustment that requires strict daily routines, patient education, and close monitoring.

Note: Fully implantable pumps placed inside the body are becoming an option in some specialized centers to avoid external lines, though they are not universally available and require surgery ^[13].

Emergency Preparedness

Because these medications must be delivered continuously, any interruption can cause a dangerous, rapid spike in your pulmonary pressures (known as rebound pulmonary hypertension) ^[11][15].

• Never stop your infusion or change your dose without direct instructions from your PAH team.
• Follow your clinic’s emergency protocol. You must carry backup supplies, extra medication, batteries, and often a backup pump at all times.
• Respond to alarms immediately. Call your PAH team or emergency services right away if your pump fails, an alarm cannot be resolved, or if you develop severe shortness of breath, chest pain, or fainting ^[16][17].
• Watch for infection. Seek urgent medical care if you notice fever, chills, or redness, pain, and drainage at your catheter or infusion site.

Timing of Lung Transplant Evaluation

Starting a pump does not mean you have run out of options, but it is an important time to plan for the future. For advanced PAH, a lung transplant evaluation is often considered concurrently while initiating pump therapy ^[15][2]. Having this evaluation early does not commit you to a transplant; it simply ensures you have a backup plan if your body does not adequately respond to the pump therapy over time.